CARDIOL THERAPEUTICS INC-A (CRDL) Stock Analyst Ratings

NASDAQ:CRDL • CA14161Y2006

1.04 USD
0 (0%)
Last: Feb 18, 2026, 08:23 PM
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to CRDL. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 7.03. This target is 576.1% above the current price.
  • CRDL was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CRDL.
  • In the previous month the buy percentage consensus was at a similar level.
  • CRDL was analyzed by 8 analysts. More opinions would make the average more meaningful.
CRDL Historical Analyst RatingsCRDL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Price Target & Forecast

Price Low Median Mean High 1.045.787.037.038.47 - 455.52% 576.10% 576.10% 714.45%
CRDL Current Analyst RatingCRDL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2026-02-10 HC Wainwright & Co. Reiterate Buy -> Buy
2025-12-01 HC Wainwright & Co. Reiterate Buy -> Buy
2025-06-02 HC Wainwright & Co. Initiate Buy
2025-04-16 HC Wainwright & Co. Reiterate Buy -> Buy
2025-04-07 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-24 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-18 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-20 HC Wainwright & Co. Reiterate Buy -> Buy
2024-10-24 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-26 Roth MKM Initiate Buy
2024-06-14 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-07 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-23 Canaccord Genuity Maintains Buy -> Buy
2024-05-14 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-22 HC Wainwright & Co. Initiate Buy
2023-08-14 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-05-19 Canaccord Genuity Maintains Buy -> Buy
2021-12-17 Cantor Fitzgerald Initiate Overweight
2021-12-03 Canaccord Genuity Initiate Buy

CARDIOL THERAPEUTICS INC-A / CRDL FAQ

What is the price target for CRDL stock?

8 analysts have analysed CRDL and the average price target is 7.03 USD. This implies a price increase of 576.1% is expected in the next year compared to the current price of 1.04.


What is the consensus rating for CARDIOL THERAPEUTICS INC-A (CRDL) stock?

The consensus rating for CARDIOL THERAPEUTICS INC-A (CRDL) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed CARDIOL THERAPEUTICS INC-A (CRDL)?

The number of analysts covering CARDIOL THERAPEUTICS INC-A (CRDL) is 8.